Target
7-protein immunohistochemistry signature (Immunoprint)
1 abstract
Abstract
Interim analysis of MelaRisk, a biomarker assay validation study in stage IB/IIA melanoma tissue.Org: Center for Dermatooncology, Department of Dermatology, Eberhard Karls University of Tuebingen, Tuebingen, Germany, Tübingen, Germany,